
Laura K. Tso
Examiner (ID: 1977, Phone: (571)272-2385 , Office: P/2875 )
| Most Active Art Unit | 2875 |
| Art Unit(s) | 2875, 3303, 3302, 2109, 2831, 2103 |
| Total Applications | 3051 |
| Issued Applications | 2669 |
| Pending Applications | 113 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6697298
[patent_doc_number] => 20030109492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Non-inclusion cyclodextrin complexes'
[patent_app_type] => new
[patent_app_number] => 10/272936
[patent_app_country] => US
[patent_app_date] => 2002-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12889
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20030109492.pdf
[firstpage_image] =>[orig_patent_app_number] => 10272936
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/272936 | Non-inclusion cyclodextrin complexes | Oct 17, 2002 | Issued |
Array
(
[id] => 6652233
[patent_doc_number] => 20030105165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Gap junctions and EDHF'
[patent_app_type] => new
[patent_app_number] => 10/270663
[patent_app_country] => US
[patent_app_date] => 2002-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9558
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20030105165.pdf
[firstpage_image] =>[orig_patent_app_number] => 10270663
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/270663 | Gap junctions and EDHF | Oct 15, 2002 | Abandoned |
Array
(
[id] => 720607
[patent_doc_number] => 07049436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-23
[patent_title] => 'Carbon dioxide compatible non-aqueous crosslinked fracturing fluids and methods for their use'
[patent_app_type] => utility
[patent_app_number] => 10/267686
[patent_app_country] => US
[patent_app_date] => 2002-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 4874
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/049/07049436.pdf
[firstpage_image] =>[orig_patent_app_number] => 10267686
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/267686 | Carbon dioxide compatible non-aqueous crosslinked fracturing fluids and methods for their use | Oct 8, 2002 | Issued |
Array
(
[id] => 6822109
[patent_doc_number] => 20030220270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Mono-and disaccharide derivatives'
[patent_app_type] => new
[patent_app_number] => 10/148441
[patent_app_country] => US
[patent_app_date] => 2002-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 26737
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20030220270.pdf
[firstpage_image] =>[orig_patent_app_number] => 10148441
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/148441 | Mono-and disaccharide derivatives | Oct 6, 2002 | Abandoned |
Array
(
[id] => 6678908
[patent_doc_number] => 20030229049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Method and pharmaceutical to treat spinal discs'
[patent_app_type] => new
[patent_app_number] => 10/441130
[patent_app_country] => US
[patent_app_date] => 2002-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2292
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20030229049.pdf
[firstpage_image] =>[orig_patent_app_number] => 10441130
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/441130 | Method and pharmaceutical to treat spinal discs | Oct 3, 2002 | Abandoned |
Array
(
[id] => 7367109
[patent_doc_number] => 20040006007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Methods and compositions for treating hepatitis C virus using 4\'-modified nucleosides'
[patent_app_type] => new
[patent_app_number] => 10/261244
[patent_app_country] => US
[patent_app_date] => 2002-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 31547
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 63
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20040006007.pdf
[firstpage_image] =>[orig_patent_app_number] => 10261244
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/261244 | Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides | Sep 29, 2002 | Issued |
Array
(
[id] => 1080677
[patent_doc_number] => 06835720
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-28
[patent_title] => 'Compounds having antiviral activity'
[patent_app_type] => B2
[patent_app_number] => 10/252036
[patent_app_country] => US
[patent_app_date] => 2002-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 20400
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/835/06835720.pdf
[firstpage_image] =>[orig_patent_app_number] => 10252036
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/252036 | Compounds having antiviral activity | Sep 22, 2002 | Issued |
Array
(
[id] => 988265
[patent_doc_number] => 06921820
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-26
[patent_title] => 'Method for forming cellulose'
[patent_app_type] => utility
[patent_app_number] => 10/247623
[patent_app_country] => US
[patent_app_date] => 2002-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 6787
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/921/06921820.pdf
[firstpage_image] =>[orig_patent_app_number] => 10247623
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/247623 | Method for forming cellulose | Sep 19, 2002 | Issued |
Array
(
[id] => 6818249
[patent_doc_number] => 20030069207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration'
[patent_app_type] => new
[patent_app_number] => 10/237918
[patent_app_country] => US
[patent_app_date] => 2002-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2808
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20030069207.pdf
[firstpage_image] =>[orig_patent_app_number] => 10237918
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/237918 | Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration | Sep 8, 2002 | Issued |
Array
(
[id] => 6852032
[patent_doc_number] => 20030144235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => '4\'-thio-L-xylofuranosyl nucleosides, precursors thereof, preparation and use thereof'
[patent_app_type] => new
[patent_app_number] => 10/237192
[patent_app_country] => US
[patent_app_date] => 2002-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5136
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20030144235.pdf
[firstpage_image] =>[orig_patent_app_number] => 10237192
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/237192 | 4′-thio-L-xylofuranosyl nucleosides, precursors thereof, preparation and use thereof | Sep 8, 2002 | Issued |
Array
(
[id] => 6792743
[patent_doc_number] => 20030088087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Synthesis, deprotection, analysis & purification of RNA & ribozymes'
[patent_app_type] => new
[patent_app_number] => 10/231874
[patent_app_country] => US
[patent_app_date] => 2002-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12018
[patent_no_of_claims] => 127
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20030088087.pdf
[firstpage_image] =>[orig_patent_app_number] => 10231874
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/231874 | Synthesis, deprotection, analysis and purification of RNA and ribozymes | Aug 29, 2002 | Issued |
Array
(
[id] => 6716577
[patent_doc_number] => 20030027925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Oligosaccharide synthesis'
[patent_app_type] => new
[patent_app_number] => 10/231909
[patent_app_country] => US
[patent_app_date] => 2002-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12130
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027925.pdf
[firstpage_image] =>[orig_patent_app_number] => 10231909
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/231909 | Oligosaccharide synthesis | Aug 29, 2002 | Issued |
Array
(
[id] => 6711824
[patent_doc_number] => 20030171573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Multivalently interactive molecular assembly, capturing agent, drug carrier, calcium chelating agent, and drug enhancer'
[patent_app_type] => new
[patent_app_number] => 10/230394
[patent_app_country] => US
[patent_app_date] => 2002-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13634
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20030171573.pdf
[firstpage_image] =>[orig_patent_app_number] => 10230394
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/230394 | Multivalently interactive molecular assembly, capturing agent, drug carrier, calcium chelating agent, and drug enhancer | Aug 28, 2002 | Abandoned |
Array
(
[id] => 6651219
[patent_doc_number] => 20030105029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Drugs, foods or drinks with the use of algae-derived physiologically active substances'
[patent_app_type] => new
[patent_app_number] => 10/228195
[patent_app_country] => US
[patent_app_date] => 2002-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 28529
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20030105029.pdf
[firstpage_image] =>[orig_patent_app_number] => 10228195
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/228195 | Drugs, foods or drinks with the use of algae-derived physiologically active substances | Aug 26, 2002 | Issued |
Array
(
[id] => 6783506
[patent_doc_number] => 20030064954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds'
[patent_app_type] => new
[patent_app_number] => 10/204640
[patent_app_country] => US
[patent_app_date] => 2002-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19725
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20030064954.pdf
[firstpage_image] =>[orig_patent_app_number] => 10204640
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/204640 | Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds | Aug 21, 2002 | Abandoned |
Array
(
[id] => 1025188
[patent_doc_number] => 06884880
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-26
[patent_title] => 'Process for the preparation of 9-β-anomeric nucleoside analogs'
[patent_app_type] => utility
[patent_app_number] => 10/225032
[patent_app_country] => US
[patent_app_date] => 2002-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6499
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/884/06884880.pdf
[firstpage_image] =>[orig_patent_app_number] => 10225032
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/225032 | Process for the preparation of 9-β-anomeric nucleoside analogs | Aug 20, 2002 | Issued |
Array
(
[id] => 6628678
[patent_doc_number] => 20030005857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-09
[patent_title] => 'Saccharide compound and a method of producing the same'
[patent_app_type] => new
[patent_app_number] => 10/223364
[patent_app_country] => US
[patent_app_date] => 2002-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7364
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20030005857.pdf
[firstpage_image] =>[orig_patent_app_number] => 10223364
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/223364 | Saccharide compound and a method of producing the same | Aug 19, 2002 | Abandoned |
Array
(
[id] => 6702152
[patent_doc_number] => 20030225032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Pharmaceutical composition'
[patent_app_type] => new
[patent_app_number] => 10/217551
[patent_app_country] => US
[patent_app_date] => 2002-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2135
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20030225032.pdf
[firstpage_image] =>[orig_patent_app_number] => 10217551
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/217551 | Pharmaceutical composition | Aug 13, 2002 | Issued |
Array
(
[id] => 6658047
[patent_doc_number] => 20030078232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Adenosine receptor A3 agonists'
[patent_app_type] => new
[patent_app_number] => 10/212896
[patent_app_country] => US
[patent_app_date] => 2002-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13859
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20030078232.pdf
[firstpage_image] =>[orig_patent_app_number] => 10212896
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/212896 | Adenosine receptor A3 agonists | Aug 4, 2002 | Abandoned |
Array
(
[id] => 7674665
[patent_doc_number] => 20040127453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Method for treating diseases associated with abnormal kinase activity'
[patent_app_type] => new
[patent_app_number] => 10/206854
[patent_app_country] => US
[patent_app_date] => 2002-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15707
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127453.pdf
[firstpage_image] =>[orig_patent_app_number] => 10206854
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/206854 | Method for treating diseases associated with abnormal kinase activity | Jul 25, 2002 | Issued |